HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $598 | +1.7% | 15,678 | -3.9% | 0.01% | +14.3% |
| Q2 2023 | $588 | -17.3% | 16,313 | -12.4% | 0.01% | -12.5% |
| Q1 2023 | $711 | -34.0% | 18,621 | -1.6% | 0.01% | -38.5% |
| Q4 2022 | $1,077 | -99.9% | 18,929 | -1.0% | 0.01% | +30.0% |
| Q3 2022 | $755,000 | -13.4% | 19,114 | -3.6% | 0.01% | -9.1% |
| Q2 2022 | $872,000 | +10.5% | 19,819 | +0.1% | 0.01% | +37.5% |
| Q1 2022 | $789,000 | -3.7% | 19,809 | -2.8% | 0.01% | 0.0% |
| Q4 2021 | $819,000 | -7.8% | 20,379 | -6.7% | 0.01% | -11.1% |
| Q3 2021 | $888,000 | -5.8% | 21,844 | +5.1% | 0.01% | -10.0% |
| Q2 2021 | $943,000 | +13.6% | 20,785 | +4.3% | 0.01% | +11.1% |
| Q1 2021 | $830,000 | -5.8% | 19,923 | -3.5% | 0.01% | -10.0% |
| Q4 2020 | $881,000 | – | 20,647 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |